Evidence map›Paper›PMID 19246768›Full record

ArticleMicrobiology (Reading, England)2009

Evaluation of procedures for outer membrane isolation from Campylobacter jejuni.

Rhonda I Hobb, Joshua A Fields, Christopher M Burns, Stuart A Thompson

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Microbiology (Reading, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
7.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Molecules (Basel, Switzerland) · 2025
    Article
  3. Defining Membrane Protein Localization by Isopycnic Density Gradients.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  4. Article
  5. Article
  6. Engineering early memory B-cell-like phenotype in hydrogel-based immune organoids.Journal of biomedical materials research. Part A · 2022
    Article
  7. Article
  8. Article
  9. TheMicroorganisms · 2021
    Article
  10. Article
  11. Article
  12. Organoid Polymer Functionality and Mode ofAdvanced functional materials · 2020
    Article
  13. Porin from Marine BacteriumMolecules (Basel, Switzerland) · 2020
    Article
  14. Article
  15. Article
  16. Development of Different Methods for PreparingFrontiers in immunology · 2020
    Article
  17. Frontiers in microbiology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rhonda I HobbDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912, USA.
Joshua A FieldsDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912, USA.
Christopher M BurnsCollege of Biomedical Science, Florida Atlantic University, Boca Raton, FL 33431, USA.
Stuart A ThompsonDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912, USA.
Augusta University · USFlorida Atlantic University · US

Funding

Campylobacter jejuni outer membrane protein vaccineR01AI058284 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI THOMPSON, STUART A · 2004 to 2009
$1.9M
Campylobacter jejuni proteins induced at 37CR01AI055715 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI THOMPSON, STUART A · 2003 to 2007
$1.4M
Campylobacter jejuni DNA methylation and gene regulationR21AI061026 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI THOMPSON, STUART A · 2004 to 2004
$320k
NIAID NIH HHS AI055715NIAID NIH HHS AI058284NIAID NIH HHS AI061026NIAID NIH HHS R01 AI055715NIAID NIH HHS R01 AI058284NIAID NIH HHS R21 AI061026
6 · The paper itself

Abstract

Although infection with Campylobacter jejuni is one of the leading causes of gastroenteritis worldwide, relatively little is known about the factors that are required to elicit a protective immune response. The need for a vaccine against this pathogen is well recognized and a number of vaccine candidates have been tested with varying degrees of success; however, there is still a lack of a suitable vaccine. To gain a better understanding of the outer-membrane protein components of this organism, a 'gold standard' method to purify the outer membrane is needed. Therefore, we attempted to develop a robust and reliable method which resulted in a pure outer-membrane fraction. A total of nine methodologies were examined and analysed by SDS-PAGE and immunoblotting using subcellular markers for the cytoplasm, cytoplasmic membrane and outer membrane. We found that glycine extraction, differential detergent extraction using Triton X-100, serial extraction using 1 M Tris pH 7, spheroplasting by lysozyme and sonication, and carbonate extraction did not produce pure outer-membrane preparations. However, we identified three methods that provided outer-membrane fractions free from subcellular contamination. Isopycnic centrifugation using a 30-60 % sucrose gradient produced seven fractions free from cytoplasmic or cytoplasmic membrane contamination; however, these fractions did not correspond as well as expected with the typical outer-membrane-associated peak (e.g. Escherichia coli or Salmonella). The spheroplast method using lysozyme alone also resulted in pure outer-membrane fraction, as did carbonate washing of this sample. The extraction of outer membranes using N-lauroylsarcosine (Sarkosyl) produced the purest and most reproducible sample. These outer-membrane preparations will be useful for future studies aimed at identifying C. jejuni surface proteins as vaccine components.

Indexed as

Bacterial Outer Membrane ProteinsCampylobacter jejuniCentrifugation, Density GradientElectrophoresis, Polyacrylamide GelOctoxynolReproducibility of ResultsSarcosineSensitivity and SpecificityBacterial Outer Membrane ProteinsOctoxynolSarcosinesarkosyl

Identifiers

PMID19246768
PMCPMC2763183
OpenAlexW2019338290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.